IN8BIO INC INAB

US Healthcare Biological Products, (No Diagnostic Substances)
$1.42
0.0%
52w: $1.21 – $2.59

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
1.211.902.59
Jun 20, 2025 Jul 2, 2026
Institutional holders
19
-3 QoQ
13F value
$5.6M
-25.5% QoQ
Smart-money holders
3
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$23.1M
Q1 2024
$6.8M
Q2 2024
$2.1M
Q3 2024
$7.7M
Q4 2024
$3.6M
Q1 2025
$1.8M
Q2 2025
$2.1M
Q3 2025
$7.5M
Q4 2025
$5.6M
Q1 2026

Number of holders

33
Q1 2024
27
Q2 2024
27
Q3 2024
27
Q4 2024
29
Q1 2025
13
Q2 2025
19
Q3 2025
22
Q4 2025
19
Q1 2026

Who owns INAB?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Alyeska Investment Group, L.P. Quant stat arb944.3K$1.4M0.0%-1.4%
FRANKLIN RESOURCES INC Long only active914.5K$1.4M0.0%Held
683 Capital Management, LLC ★2Fundamental diversified724.6K$1.1M0.1%Held
Stonepine Capital Management, LLC ★2Fundamental concentrated663.4K$982K0.9%+302.3%
BIOS Capital Management, LP ★2Fundamental diversified167.8K$248K0.5%-33.8%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical88.9K$132K0.0%
GEODE CAPITAL MANAGEMENT, LLC Index provider86.2K$128K0.0%+311.3%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical43.6K$65K0.0%
CAPTRUST FINANCIAL ADVISORS Wealth advisor33.3K$49K0.0%+82.0%
OPPENHEIMER & CO INC Diversified mechanical24.0K$36K0.0%New
Texas Capital Bank Wealth Management Services Inc Wealth advisor23.8K$35K0.0%Held
NORTHERN TRUST CORP Index provider20.4K$30K0.0%+17.5%
XTX Topco Ltd Market maker12.4K$18K0.0%-27.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO Insurance2.8K$4K0.0%Held
Tower Research Capital LLC (TRC) Market maker1.3K$2K0.0%-48.4%
JONES FINANCIAL COMPANIES LLLP Wealth advisor768$1K0.0%-37.5%
UBS Group AG Bank broker480$7100.0%-38.2%
BlackRock, Inc. Index provider84$1240.0%Held
Rockefeller Capital Management L.P. Diversified mechanical83$1230.0%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.